Missouri lawmakers have approved a bill to research the restorative potential of psychedelics, such as psilocybin, MDMA, and ketamine.
The bill is part of two proposals seeking reform in how veterans are treated and heard.
- The
proposed measure would allow the state Department of Health and Human
Services to collaborate with a U.S. Department of Veterans Affairs (VA)
hospital in exploring the potential therapeutic advantages of
psychedelics.
- Conditions include PTSD, severe depression, substance misuse disorder, and end-of-life care.
- The House Veterans Committee unanimously voted to approve the bill proposed by Rep. Dan Houx.
- The
bill's proponents praised the treatment, noting its capacity to
significantly alter lives with few sessions and extensive research
backing the efforts up.
- More than a dozen U.S. states have suggested legislation decriminalizing or legalizing psychedelic substances, including ketamine, MDMA, and psilocybin.